Published in Int J Mol Sci on October 14, 2016
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (2013) 11.01
Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol (2003) 7.15
Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics (2006) 4.44
Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. J Mol Biol (1995) 2.39
Matrix metalloproteinases as valid clinical targets. Curr Pharm Des (2007) 1.76
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1. Proc Natl Acad Sci U S A (2012) 1.46
Transient collagen triple helix binding to a key metalloproteinase in invasion and development. Structure (2015) 1.45
Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity. J Biol Chem (2009) 1.30
Structural basis for matrix metalloproteinase 1-catalyzed collagenolysis. J Am Chem Soc (2012) 1.21
Matrix metalloproteinase dependent and independent collagen degradation. Front Biosci (2006) 1.09
Interdomain flexibility in full-length matrix metalloproteinase-1 (MMP-1). J Biol Chem (2009) 1.02
The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite. J Biol Chem (2011) 0.97
Examination of matrix metalloproteinase-1 in solution: a preference for the pre-collagenolysis state. J Biol Chem (2013) 0.95
Peptide hydrolysis catalyzed by matrix metalloproteinase 2: a computational study. J Phys Chem B (2008) 0.86
Screening of matrix metalloproteinases available from the protein data bank: insights into biological functions, domain organization, and zinc binding groups. J Chem Inf Model (2007) 0.85
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields. Biochim Biophys Acta (2015) 0.84
Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies. Expert Rev Proteomics (2015) 0.80
Kinetic and binding effects in peptide substrate selectivity of matrix metalloproteinase-2: Molecular dynamics and QM/MM calculations. Proteins (2010) 0.79
Conformational Dynamics, Ligand Binding and Effects of Mutations in NirE an S-Adenosyl-L-Methionine Dependent Methyltransferase. Sci Rep (2016) 0.79
Importance of the Linker Region in Matrix Metalloproteinase-1 Domain Interactions. RSC Adv (2016) 0.78
How does conformational flexibility influence key structural features involved in activation of anaplastic lymphoma kinase? Mol Biosyst (2014) 0.77